Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
MARKHAM, ON, Jan. 30, 2024 /CNW/ - Today, Astellas Pharma Canada, Inc. announced that Health Canada has approved a supplemental New Drug Application for XTANDI® (enzalutamide) in a new prostate...
XTANDI is the only treatment approved for three clinical disease states across four indications, and the improved access for mCSPC patients will support earlier treatment MARKHAM, ON, June 23, 2022...
MARKHAM, ON, April 29, 2022 /CNW/ - Astellas Pharma Canada, Inc., headquartered in Markham, Ontario a leader in innovative medicines, recognizes the Ontario government for the commitment of...
Astellas ranked 47th on the Best Workplaces™ in Canada list MARKHAM, ON, April 27, 2022 /CNW/ - Astellas Pharma Canada, Inc. has been named again on the list of Best Workplaces™ in Canada by the...
Having access to an additional treatment option offers hope for Canadian adult AML patients with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation. MARKHAM, ON, April 21, 2022...
As a leader in the field of transplantation, Astellas is recognized for its continued commitment to driving awareness and access to organ donation MARKHAM, ON, Sept. 15, 2021 /CNW/ - In conjunction...
Astellas ranked 38 on the Best Workplaces™ in Canada list MARKHAM, ON, April 14, 2021 /CNW/ - Astellas Pharma Canada, Inc. has been recognized on the 2021 list of Best Workplaces™ in Canada by the...
XTANDI® is the first and only androgen receptor-axis-targeted therapy (ARAT) approved by Health Canada in three clinical disease states of prostate cancer across four indications2 MARKHAM, ON, June...
Astellas ranked 27 on the Great Place to Work® Institute's Best Workplaces™ in Canada list, in addition to recognition on the 2020 lists of Best Workplaces™ in Canada for Inclusion and Women MARKHAM, ...
XOSPATA is the first and only targeted treatment approved by Health Canada for patients with relapsed or refractory Acute Myeloid Leukemia with a FLT3 mutation. The approval of XOSPATA marks...
Partners with Variety Village to make a positive impact in local Canadian communities TORONTO, Oct. 21, 2019 /CNW/ - Today, more than 80 Astellas Pharma Canada ("Astellas") employees will step away...
Astellas ranked 22nd on the Best Workplaces™ in Canada list, in addition to recognition on the 2019 lists of Best Workplaces™ in Canada for Giving Back, Inclusion and Women MARKHAM, ON , April 29,...
MARKHAM, ON, Jan. 15, 2019 /CNW/ - Astellas Pharma Canada, Inc. is proud to announce that the Company has been named on the 2019 list of Best Workplaces™ for Inclusion. Astellas received this...
MARKHAM, ON, Jan.14, 2019 /CNW/ - Astellas Pharma Canada, Inc., today announced that Health Canada approved an expanded indication for enzalutamide, an androgen receptor inhibitor for the treatment...
Through their stories, this initiative aims to celebrate and honour the lives of older Canadians MARKHAM, ON, July 5, 2018 /CNW/ - Aligned with a strong commitment to making a difference in the...
2018 Challenge Will Award a Total of $100,000 in New Grants to Help Reduce the Unequal Burden of Cancer All Healthcare Innovators Encouraged to Apply MARKHAM, ON, June 12, 2018 /CNW/ - Astellas...
For the third consecutive year, Astellas makes the Best Workplace in Canada list, ranking 21st, along with Best in Large and Multinational Workplace, and a Best Workplace for Women in Canada MARKHAM, ...
TORONTO, Nov. 20, 2017 /CNW/ - Astellas Pharma Canada, Inc. ("Astellas") is asking Leafs' fans and anyone who wants to help find a cure for prostate cancer to take selfies using the hashtag...
Campaign supports research and awareness for prostate cancer, the most commonly diagnosed cancer among Canadian men MARKHAM, ON, Nov. 1, 2017 /CNW/ - Men, and their loved ones, across Canada just...
Inclusion and Diversity Highlighted in Corporate Day Dedicated to Community Service TORONTO, Oct. 25, 2017 /CNW/ - Today, more than 150 Astellas Pharma Canada, Inc. ("Astellas") employees are helping ...
Announcing the Winners of The Canadian Society of Transplantation (CST) – Astellas T3 Competition HALIFAX, Sept. 27, 2017 /CNW/ - In a recreation of the popular TV show Dragons' Den, delegates at the ...
- Three grants totaling $100,000 will be awarded to help bring new innovations to life - TORONTO, July 12, 2017 /CNW/ - Astellas Pharma Canada, Inc. (Astellas) and the Canadian Society of...
The challenge is open to nearly anyone with a tangible, unique idea to improve cancer care. Robert Herjavec, technology entrepreneur, star of ABC's Emmy Award-winning hit television show Shark Tank,...
MARKHAM, ON, June 1, 2017 /CNW/ - Astellas Pharma Canada, Inc. (Astellas) announced today an increased commitment to innovation in the field of transplantation through support for the Canadian...
Astellas ranked 24th Best in Large and Multinational Workplace and 28th Best Workplace for Women in Canada MARKHAM, ON, April 27, 2017 /CNW/ - Astellas Pharma Canada, Inc. (Astellas), the Canadian...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.